Morgan Stanley Upgrades ResMed (RMD) to Overweight
Get Alerts RMD Hot Sheet
Price: $198.03 +0.87%
Rating Summary:
13 Buy, 9 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 11 | New: 11
Rating Summary:
13 Buy, 9 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 11 | New: 11
Join SI Premium – FREE
Morgan Stanley upgraded ResMed (NYSE: RMD) from Equalweight to Overweight.
For an analyst ratings summary and ratings history on ResMed click here. For more ratings news on ResMed click here.
Shares of ResMed closed at $56.12 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BofA Securities Upgrades Estee Lauder (EL) to Buy; 'Earnings have bottomed'
- Cleveland-Cliffs (CLF) lifted to buy at GLJ Research as it looks like 'smooth sailing' ahead
- HSBC Upgrades Xinte Energy Co Ltd (1799:HK) to Hold, 'cost cutting efforts likely to keep away from loss making'
Create E-mail Alert Related Categories
Hot Upgrades, UpgradesRelated Entities
Morgan StanleySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!